Hapbee, EMulate, HAPB

A Medical Technology That Has The Highest Potential Over Any We Follow.

You Must Read This... New Report on the People Behind EMulate Therapeutics. 200 Million...
Hapbee

Jim Kwik and Kevin Harrington Join Hapbee Technologies (HAPB) Board.

Hapbee Announces Additions to Advisory Board December 17, 2020 New Advisors Bring Decades of Entrepreneurial ExperienceWellness...
HAPBEE

Hapbee (HAPB): The Netflix of Feelings

After 15 years, $70 million spent on R&D, and 350,000+ hours of testing, this "Netflix of Feelings" wearable technology is finally...
Hapbee, Biotech Stock Review

Scott Donnell Used His Intuition to Launch Hapbee (HAPB). Video.

My next guest, Scott Donnell, who is a serial entrepreneur and CEO of Hapbee (www.hapbee.com), had a knack for business early in...
BioSig, Biotech Stock Review

BioSig (BSGM) Achieves First Commercial Sale of Three PURE EP Systems

Sale Marks Milestone for Company's Commercial expansion at leading Center of Excellence Westport,...
Internet Stock Review

Newsletter: Institutional Analyst. And Yes, We Have Another Double.

1. Dalrada (DFCO) $0.19. And Yes, We Have Another Double!2. Dyadic (DYAI) $6.40. We're Up 392%, Video Presentation.3....
Dalrada

Dalrada (DFCO) Finally Pops. Up 59% Today.

Up 59% today on news and with 4 million shares trading and counting! LIVE QUOTE
Hapbee

Adding Hapbee (HAPB) to the Watch List.

Listed on TSX under HAPB, we're officially price and time stamping our interest in this amazing little technology Company by adding it...
Hapbee

Hapbee’s (HAPB) Device, “Choose How You Feel.”

HAPBEE ANNOUNCES LAUNCH OF A SUBSCRIPTION-BASED WELLBEING WEARABLE, PROVIDING MEMBERS THE ABILITY TO CHOOSE 'HOW THEY FEEL' Proprietary, Research-Backed...
Mark Washo, Aphex Biocleanse

Aphex BioCleanse Systems Appoints Respected Marketing Veteran Mark Washo as Senior Vice President of...

PITTSFORD, N.Y., Nov. 12, 2020 PITTSFORD, N.Y. , Nov. 12, 2020 /PRNewswire/ -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST) ("Aphex" or "the Company") , a sanitization...

Latest article

Citius, Biotech Stock Review

Adding Citius Pharma (CTXR) $1.29 to the 2021 Biotech Portfolio.

The 2021 Biotech Six Pack, Six Stocks We Expect to Double. We're still putting the 2021 list together now,...
Mitesco, Biotech Stock Review, roland rick perry

Short Squeeze Mania.

Citius Pharma (CTXR) Locked and Loaded. Truly Locked and Loaded. Latest $20 Million Round is Biggest News We've Seen...

Video: Pacific Stem Cell

With nearly a third of the US suffering from chronic pain, and over a million patients a year having joint replacements, affordable...